Loading stock data…
$10.59-0.16 (-1.49%)
Phreesia, Inc.
Phreesia, Inc. in the Healthcare sector is trading at $10.65 with a market capitalization of $638M. Wall Street consensus targets $14.13 (15 analysts), implying a +32.7% move over the next 12 months. The stock is currently near its 52-week low of $7.77, remaining 5.0% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Total Revenue | $129.46M↓ | $130.94M↑ | $127.07M↑ | $120.33M↑ | $117.25M |
| Gross Profit | $86.27M↓ | $87.60M↑ | $86.68M↑ | $82.31M↑ | $79.61M |
| Operating Income | $7.61M↑ | $6.75M↑ | -$5.56M↓ | $3.74M↑ | -$1.51M |
| Net Income | $1.92M↓ | $2.96M↑ | $1.29M↓ | $4.27M↑ | $654,000 |
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and...